Altrova Health to Present at the Life Sciences Investor Forum on September 17th

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Altrova Health to Present at the Life Sciences Investor Forum on September 17thAuthor of the article:The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.comTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountTORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) (“Altrova Health” or the “Company”), based in Canada, focused on health, safety, and rapid response technologies, today announced that Geoff Benic, Chief Executive Officer, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026DATE: September 17thTIME: 2:30 PM ETGet the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againThe event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference.It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Recent Company HighlightsExclusive U.S. Distribution Agreement – The Company entered into an exclusive distribution agreement with Reliability Funding LLC (“Reliability”), appointing Reliability as its exclusive sales agent and distributor for the Company’s detection, protection and wellness product portfolio across the United States (excluding the NIRLAB SA (“NIRLAB”) NIRLIGHT device). The agreement has an initial two-year term with renewal tied to agreed performance thresholds, and Reliability is compensated through a share of profit on U.S. sales. Concurrently, the Company announced a non-brokered private placement for gross proceeds of up to US$500,000 to fund inventory, customer onboarding and sales support for the U.S. launch.First Commercial Revenue in Company History – For the nine months ended June 30, 2026, the Company reported revenue of $112,000, up from $15,551 in the prior comparative period, as distribution and commercialization initiatives began converting into recurring commercial activity. General and administrative, investor relations and professional fees each declined year-over-year even as commercial operations scaled.Board Leadership Transition – The Board appointed The Hon. Tony Clement as Chairman of the Board of Directors of Altrova Health. The Company also continued to expand its distribution network through NIRLAB device sales, partnerships with Indigenous and First Nations communities, and a planned relaunch of the Drug Lab 118 Ltd. rapid detection strip portfolio.About Altrova Health Inc.Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company’s current product portfolio includes exclusive Canadian distribution rights for the NIRLAB SA (“NIRLAB“) NIRLIGHT drug analysis device, the O-Spray product line, and the rapid detection strip portfolio of its subsidiary Drug Lab 118 Ltd.For more information, please visit: www.altrovahealth.comAbout Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.CONTACTS:Geoff BenicChief Executive OfficerAltrova Health Inc.Email: geoff@altrovahealth.comPhone: +1 647-880-7314Website: www.altrovahealth.comVirtual Investor Conferences Greg YoungVP Corporate Services, Investor AccessOTC Markets Group (212) 652-5958greg@otcmarkets.comThis advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.